FdaApplication
ANDA 211232
Identifiers
- fda_app_no: ANDA211232
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-08-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ETHACRYNIC ACID | ETHACRYNIC ACID | 25MG | TABLET;ORAL |
1 product